A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients

CONCLUSIONS: Among 31 episodes of HSV treated with foscarnet, only half resolved with treatment, and adverse events were common.PMID:38444818 | PMC:PMC10914364 | DOI:10.1093/ofid/ofae046

Source: Herpes - March 6, 2024 Category: Infectious Diseases Authors: Sarah P Hammond Manickam Rangaraju Melanie Sumner Burkhard Timmler Pranatharthi Chandrasekar Robin K Avery Source Type: research